Digital Therapeutics in Addiction
Smartphone-based recovery, AI relapse prediction and remote contingency management have moved from research pilots to reimbursable clinical tools. The session covers Pear Therapeutics post-bankruptcy lessons, DynamiCare contingency management at scale, Sword Health and Hinge equivalents for addiction recovery, wearable physiological prediction of relapse, app-based CBT delivery, and the new Remote Therapeutic Monitoring (RTM) CPT codes that enable billing. Discussion addresses digital equity, data privacy under 42 CFR Part 2 revisions, integration with EHRs and telehealth MAT, FDA digital-therapeutic regulatory pathway, and which programmes have demonstrated real-world adherence improvement versus pilot-only results.
- Smartphone contingency management
- Wearable relapse prediction
- App-based CBT
- RTM code billing
- Digital therapeutic FDA pathway
- 42 CFR Part 2 revisions
- Pear Therapeutics lessons
- Telehealth MAT integration
Explore the full WCAM 2027 program
- 01Opioid Use Disorder
- 02Alcohol Use Disorder
- 03Stimulants & Polysubstance Use
- 04Behavioral Addictions
- 05Harm Reduction
- 06Medication-Assisted Treatment
- 07Recovery Support Services
- 08Prevention & Early Intervention
- 09Neuroscience of Addiction
- 10Trauma & PTSD-Related Use
- 11Adolescent Addiction
- 12Pregnancy & Addiction
- 13Co-occurring Mental Illness
- 14Tobacco & Nicotine Cessation
- 15Cannabis Use Disorder
- 16Psychedelic-Assisted Therapy
- 18Addiction Policy & Public Health
- 19Methadone & Buprenorphine Programs
- 20Naloxone & Overdose Prevention
- 21Recovery Housing
- 22Peer Support Specialists
- 23Addiction Medicine Training
- 24Stigma & Communication
- 25Drug Policy Reform
- 26International Drug Trends
- 27Older Adults & Addiction
- 28Veterans & Addiction
- 29Criminal Justice & Treatment
- 30Family Therapy
- 31Spirituality & Recovery
- 32Genetics of Addiction
- 33Polysubstance Use Trends
- 34Emerging Drugs of Abuse
- 35Workforce Development